7VQP image
Deposition Date 2021-10-20
Release Date 2022-03-09
Last Version Date 2023-11-29
Entry Detail
PDB ID:
7VQP
Keywords:
Title:
Vitamin D receptor complexed with a lithocholic acid derivative
Biological Source:
Source Organism:
Rattus norvegicus (Taxon ID: 10116)
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.94 Å
R-Value Free:
0.24
R-Value Work:
0.20
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Vitamin D3 receptor
Chain IDs:A
Chain Length:271
Number of Molecules:1
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Molecule:Mediator of RNA polymerase II transcription subunit 1
Gene (Uniprot):MED1
Chain IDs:B (auth: C)
Chain Length:13
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Lithocholic Acid Amides as Potent Vitamin D Receptor Agonists.
Biomolecules 12 ? ? (2022)
PMID: 35053278 DOI: 10.3390/biom12010130

Abstact

1α,25-Dihydroxyvitamin D3 [1α,25(OH)2D3, 1] is an active form of vitamin D3 and regulates various biological phenomena, including calcium and phosphate homeostasis, bone metabolism, and immune response via binding to and activation of vitamin D receptor (VDR). Lithocholic acid (LCA, 2) was identified as a second endogenous agonist of VDR, though its potency is very low. However, the lithocholic acid derivative 3 (Dcha-20) is a more potent agonist than 1α,25(OH)2D3, (1), and its carboxyl group has similar interactions to the 1,3-dihydroxyl groups of 1 with amino acid residues in the VDR ligand-binding pocket. Here, we designed and synthesized amide derivatives of 3 in order to clarify the role of the carboxyl group. The synthesized amide derivatives showed HL-60 cell differentiation-inducing activity with potency that depended upon the substituent on the amide nitrogen atom. Among them, the N-cyanoamide 6 is more active than either 1 or 3.

Legend

Protein

Chemical

Disease

Primary Citation of related structures